Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas
This study has been completed.
Study NCT00001165 Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999 Last Updated: March 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Islet Cell Adenoma
Neoplasm Metastasis
Zollinger Ellison Syndrome
Additional conditions recognized in this trial
Adenoma
Adenoma, Islet Cell
Gastrinoma
Neoplasms
Syndrome
Zollinger-Ellison Syndrome
More general conditions related to this trial
Adenocarcinoma
Carcinoma
Carcinoma, Islet Cell
Digestive System Diseases
Digestive System Neoplasms
Disease
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplastic Processes
Pancreatic Diseases
Pancreatic Neoplasms
Paraneoplastic Endocrine Syndromes
Paraneoplastic Syndromes
Pathologic Processes
Peptic Ulcer
Stomach Diseases
Additional drug interventions recognized in this trial
Doxorubicin
Fluorouracil
Streptozocin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Back to top of Main Content
